About the Authors

Grant D. Trobridge

Affiliations Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America

Robert A. Wu

Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Brian C. Beard

Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Sum Ying Chiu

Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Nina M. Muñoz

Affiliation Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

Dorothee von Laer

Affiliation Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany

John J. Rossi

Affiliation Department of Molecular Biology, Beckman Research Institute of City of Hope, Duarte, California, United States of America

Hans-Peter Kiem

hkiem@fhcrc.org

Affiliations Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Pathology, University of Washington, Seattle, Washington, United States of America

Competing Interests

D.v.L. is participator in the biotech company Vision7 GmbH, which holds intellectual property on membrane-anchored anti-HIV C peptides. D.v.L. is co-inventor of membrane-anchored antiviral C peptides. J.J.R. is a Scientific Advisor to Benitec, Inc., an shRNA gene therapy company.

Author Contributions

Conceived and designed the experiments: GDT HPK. Performed the experiments: GDT RAW BCB SYC NMM. Analyzed the data: GDT RAW SYC DvL JJR HPK. Contributed reagents/materials/analysis tools: DvL JJR. Wrote the paper: GDT HPK.